跳至主要内容
临床试验/NCT02860572
NCT02860572已完成不适用

Non-interventional Follow-up Versus Fluid Bolus in RESPONSE to Oliguria in the Optimization Phase of Fluid Therapy in the Critically Ill (the RESPONSE Trial)

Helsinki University Central Hospital3 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2017年1月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
130
试验地点
3
主要终点
Change in individual mean cumulative urine output (mL/kg/h)

研究概览

简要总结

Background: After hypotension, oliguria (urine output less than 0.5 mL/kg/h) was the most common trigger to administer fluid bolus in a multinational practice survey in intensive care. The effect of fluid bolus on cardiovascular variables can be very short-lived among patients in shock suggesting that fluid boluses in the optimization phase are unlikely to improve patient-centered outcomes. Moreover, a growing body of evidence suggests a poor renal response to fluid bolus.

Objective: To investigate, whether fluid bolus - as a standard of care - improves urine output in oliguric patients compared to a non-interventional follow-up approach without fluid bolus.

Design: Investigator-initiated, open, randomized, controlled study

Interventions:

  1. Intervention group - follow-up without intervention
  2. Control group - fluid bolus (500mL of balanced crystalloid over 30 minutes)

Randomization: 1:1 stratified according to the site, presence of acute kidney injury, and sepsis

Trial size: 130 patients randomized in 2 ICUs

详细描述

Study hypothesis:

The investigators hypothesize that fluid bolus given due to oliguria does not improve urine output in a majority of patients, especially among those with acute kidney injury. Another study hypothesis is that patients receiving fluid bolus will have higher levels of endothelial damage biomarkers.

Intervention description:

Intervention group -follow-up without intervention; No intervention to increase the urine output within 2 hours will be done.

Standard group - Fluid bolus group: Patient will receive 500mL of balanced crystalloid intravenously over 30 minutes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 18
  • Emergency admission to an ICU
  • Mean arterial pressure (MAP) >65 mmHg (with vasopressors if needed) and initial fluid resuscitation for shock/hypovolemia has been given
  • Oliguria (urine output less than 0.5mL/kg/h) for at least 2 consecutive hours

排除标准

  • Marked fluctuations in hemodynamics within last 2 hours (cardiac arrhythmias, increase in norepinephrine need over 0.2ug/kg/min, need for initiation of inotrope/inodilator)
  • Administration of furosemide within last 6 hours
  • Chronic kidney disease (estimated pre-critical illness GFR < 60ml/min/1.73m2)
  • Renal replacement therapy
  • Among patients with acute kidney injury, urgent indications for commencing renal replacement therapy
  • Fluid overload (cumulative fluid accumulation exceeds 10% of baseline body weight)
  • Pulmonary edema (bilateral infiltrates in chest x-ray)
  • Active bleeding (need for transfusion, platelets, or fresh frozen plasma)
  • Suspected or known intra-abdominal hypertension (IAP >16mmHg)
  • Pregnant or lactating
  • Expected survival less than 24h
  • Obtaining informed consent is not possible/consent is denied

结局指标

主要结局

Change in individual mean cumulative urine output (mL/kg/h)

时间窗: 2 hours after randomization compared to urine output 2 hours preceding randomization

Doubling of the urine output is defined as clinically meaningful response

次要结局

  • The difference between groups in the change in individual urine output(2 hours after randomization compared to urine output 2 hours preceding randomization)
  • Duration of consecutive oliguria (urine output <0.5 mL/kg)(during ICU stay, i.e. as long as urine output stays below 0.5 mL/kg/h while the patient is in the ICU (an average of 5 to 7 days) or until renal replacement therapy is commenced)
  • Cumulative fluid balance(six hours from randomization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Suvi Vaara

MD, PhD

Helsinki University Central Hospital

研究点 (3)

Loading locations...

相似试验

Non-interventional Follow-up Versus Fluid Bolus in... | 临床试验